Correlation Between Rimon Consulting and Insuline Medical

Can any of the company-specific risk be diversified away by investing in both Rimon Consulting and Insuline Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rimon Consulting and Insuline Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rimon Consulting Management and Insuline Medical, you can compare the effects of market volatilities on Rimon Consulting and Insuline Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rimon Consulting with a short position of Insuline Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rimon Consulting and Insuline Medical.

Diversification Opportunities for Rimon Consulting and Insuline Medical

-0.67

Correlation Coefficient

Rimon Consulting  Insuline Medical

Excellent diversification

The 3 months correlation between Rimon and Insuline is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Rimon Consulting Management and Insuline Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insuline Medical and Rimon Consulting is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rimon Consulting Management are associated (or correlated) with Insuline Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insuline Medical has no effect on the direction of Rimon Consulting i.e., Rimon Consulting and Insuline Medical go up and down completely randomly.

Pair Corralation between Rimon Consulting and Insuline Medical

Assuming the 90 days trading horizon Rimon Consulting Management is expected to under-perform the Insuline Medical. But the stock apears to be less risky and, when comparing its historical volatility, Rimon Consulting Management is 2.8 times less risky than Insuline Medical. The stock trades about -0.06 of its potential returns per unit of risk. The Insuline Medical is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  19,600  in Insuline Medical on December 30, 2024 and sell it today you would earn a total of  4,780  from holding Insuline Medical or generate 24.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Rimon Consulting Management  vs.  Insuline Medical

Rimon Consulting Man

Risk-Adjusted Performance

Very Weak

Over the last 90 days Rimon Consulting Management has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Insuline Medical

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Insuline Medical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Insuline Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Rimon Consulting and Insuline Medical

The main advantage of trading using opposite Rimon Consulting and Insuline Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rimon Consulting position performs unexpectedly, Insuline Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insuline Medical will offset losses from the drop in Insuline Medical's long position.

The idea behind Rimon Consulting Management and Insuline Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.